The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AVTR | -47.58% | -68.57% | -20.66% | -34% |
| S&P | +14.39% | +76.41% | +12.02% | +143% |
Avantor, Inc. engages in providing mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
A bruised balance sheet, a massive impairment, and a stock down substantially, but one manager has made Avantor its biggest bet.
One fund has turned nearly a third of its portfolio into a bet that this beaten-down science supplier is due for a rebound.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.66B | -1.4% |
| Gross Profit | $448.30M | -8.3% |
| Gross Margin | 26.95% | -2.0% |
| Market Cap | $7.81B | -45.5% |
| Market Cap / Employee | $578.79K | 0.0% |
| Employees | 13.5K | 0.0% |
| Net Income | $52.40M | -89.5% |
| EBITDA | $239.30M | -18.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $365.40M | 39.5% |
| Accounts Receivable | $1.07B | 3.9% |
| Inventory | 818.2 | 11.9% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $4.07B | 20.4% |
| Short Term Debt | $64.30M | -92.4% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -4.44% | -10.1% |
| Return On Invested Capital | 4.72% | 1.4% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $117.20M | -19.6% |
| Operating Free Cash Flow | $152.70M | -11.9% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 56.93 | 20.21 | 15.46 | 13.37 | -66.62% |
| Price to Book | 1.85 | 1.50 | 1.35 | 1.40 | -45.67% |
| Price to Sales | 1.65 | 1.38 | 1.29 | 1.19 | -43.97% |
| Price to Tangible Book Value | -3.75 | -3.23 | -3.01 | -2.91 | -26.02% |
| Price to Free Cash Flow TTM | 16.60 | 16.51 | 16.25 | 15.73 | -24.34% |
| Enterprise Value to EBITDA | 59.06 | 51.29 | 49.87 | 48.27 | -22.61% |
| Free Cash Flow Yield | 6.0% | 6.1% | 6.2% | 6.4% | 32.17% |
| Return on Equity | 12.5% | 11.7% | -1.5% | -9.2% | -172.50% |
| Total Debt | $4.11B | $4.24B | $3.86B | $4.13B | -2.29% |
No podcast episodes available.
AVTR earnings call for the period ending September 30, 2021.
AVTR earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
